The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias

Genes & Immunity, Published online: 02 March 2020; doi:10.1038/s41435-020-0094-8The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias
Source: Genes and Immunity - Category: Genetics & Stem Cells Authors: Source Type: research
More News: Genetics | Leukemia